#	Pagina
attuale pagina	/open-h2020/projects/198788/index.html
-1	/open-h2020/projects/207866/index.html
-2	/open-h2020/projects/226609/index.html
-3	/open-h2020/projects/214654/index.html
-4	/open-h2020/per-topic/ocsic/list/index.html
-5	/open-h2020/per-topic/potentiometry/list/index.html
-6	/open-h2020/per-topic/knock/list/index.html
-7	/open-h2020/projects/212127/index.html
-8	/open-h2020/projects/214087/index.html
-9	/open-h2020/projects/225861/index.html
-10	/open-h2020/projects/194981/index.html

Opendata, web and dolomites

TETRA TERMINATED

Autologous Stem Cell Seeded Tissue Engineered Trachea

Total Cost €

EC-Contrib. €

Partnership

Views

Outcomes and
results

TETRA project word cloud

Explore the words cloud of the TETRA project. It provides you a very rough idea of what is the project "TETRA" about.

susceptible commercial sme market conduct scaffolds life estimate dying orphan patient tracheal deaths dossier limited subjected surgical infection thousands seeded unmet route stem cells diseases repeated 11 risk eliminate 517 million synthetic organs plan length savings atmp disease maa prototype tissues 827 indication manufacturing limitations severe cell led structural data compassionate prepare strategies patients pivotal interventions platform trial treating tetra rate group generate submission successful inspire gmp efficacy benefits transplants scaffold replacements lives 48 quality tens validated insertion poorly 20 therapeutic preliminary stent follow liver competitor autologous accelerated airway hospitalised reduce 22 standard surviving care bowel clinical

Project "TETRA" data sheet

The following table provides information about the project.

Coordinator	VIDEREGEN LIMITED Organization address address: INNOVATION CENTRE 1, LIVERPOOL SCIENCE PARK, 131 M ANT city: LIVERPOOL postcode: L3 5TF website: n.a. contact info title: n.a. name: n.a. surname: n.a. function: n.a. email: n.a. telephone: n.a. fax: n.a.
Coordinator Country	United Kingdom [UK]
Project website	http://www.tetra-h2020.eu/
Total cost	6˙828˙887 €
EC max contribution	6˙828˙884 € (100%)
Programme	1. H2020-EU.3.1.3. (Treating and managing disease)
Code Call	H2020-PHC-2015-single-stage_RTD
Funding Scheme	RIA
Starting year	2016
Duration (year-month-day)	from 2016-01-01 to 2019-12-31

Partnership

Take a look of project's partnership.

#	participants	country	role	EC contrib. [€]
1	VIDEREGEN LIMITED VIDEREGEN LIMITED Organization address address: INNOVATION CENTRE 1, LIVERPOOL SCIENCE PARK, 131 M ANT city: LIVERPOOL postcode: L3 5TF website: n.a. contact info title: n.a. name: n.a. surname: n.a. function: n.a. email: n.a. telephone: n.a. fax: n.a.	UK (LIVERPOOL)	coordinator	1˙563˙340.00
2	TMC PHARMA SERVICES LIMITED TMC PHARMA SERVICES LIMITED Organization address address: Lodge Farm Barn, Elvetham Park Estate city: Hartley Wintney postcode: RG27 8AS website: n.a. contact info title: n.a. name: n.a. surname: n.a. function: n.a. email: n.a. telephone: n.a. fax: n.a.	UK (Hartley Wintney)	participant	1˙127˙146.00
3	KLINIKUM RECHTS DER ISAR DER TECHNISCHEN UNIVERSITAT MUNCHEN KLINIKUM RECHTS DER ISAR DER TECHNISCHEN UNIVERSITAT MUNCHEN Organization address address: ISMANINGER STRASSE 22 city: MUENCHEN postcode: 81675 website: http://www.med.tu.muenchen.de contact info title: n.a. name: n.a. surname: n.a. function: n.a. email: n.a. telephone: n.a. fax: n.a.	DE (MUENCHEN)	participant	903˙250.00
4	UNIVERSITY COLLEGE LONDON HOSPITALSNHS FOUNDATION TRUST UNIVERSITY COLLEGE LONDON HOSPITALSNHS FOUNDATION TRUST Organization address address: EUSTON ROAD 250 city: LONDON postcode: NW1 2PG website: n.a. contact info title: n.a. name: n.a. surname: n.a. function: n.a. email: n.a. telephone: n.a. fax: n.a.	UK (LONDON)	participant	669˙578.00
5	NHS BLOOD AND TRANSPLANT NHS BLOOD AND TRANSPLANT Organization address address: OAK HOUSE REEDS CRESCENT city: WATFORD postcode: WD24 4QN website: www.nhsbt.nhs.uk contact info title: n.a. name: n.a. surname: n.a. function: n.a. email: n.a. telephone: n.a. fax: n.a.	UK (WATFORD)	participant	535˙250.00
6	MANCHESTER UNIVERSITY NHS FOUNDATION TRUST MANCHESTER UNIVERSITY NHS FOUNDATION TRUST Organization address address: OXFORD ROAD city: MANCHESTER postcode: M13 9WL website: www.cmft.nhs.uk contact info title: n.a. name: n.a. surname: n.a. function: n.a. email: n.a. telephone: n.a. fax: n.a.	UK (MANCHESTER)	participant	483˙512.00
7	UNIVERSITY COLLEGE LONDON UNIVERSITY COLLEGE LONDON Organization address address: GOWER STREET city: LONDON postcode: WC1E 6BT website: n.a. contact info title: n.a. name: n.a. surname: n.a. function: n.a. email: n.a. telephone: n.a. fax: n.a.	UK (LONDON)	participant	455˙118.00
8	INSTYTUT GRUZLICY I CHOROB PLUC INSTYTUT GRUZLICY I CHOROB PLUC Organization address address: UL. PLOCKA 26 city: WARSZAWA postcode: 1138 website: www.igichp.edu.pl contact info title: n.a. name: n.a. surname: n.a. function: n.a. email: n.a. telephone: n.a. fax: n.a.	PL (WARSZAWA)	participant	365˙000.00
9	UNIVERSITA DEGLI STUDI DI BRESCIA UNIVERSITA DEGLI STUDI DI BRESCIA Organization address address: PIAZZA MERCATO 15 city: BRESCIA postcode: 25121 website: www.unibs.it contact info title: n.a. name: n.a. surname: n.a. function: n.a. email: n.a. telephone: n.a. fax: n.a.	IT (BRESCIA)	participant	346˙266.00
10	CELL THERAPY CATAPULT LIMITED CELL THERAPY CATAPULT LIMITED Organization address address: 12TH FLOOR TOWER WING GUY'S HOSPITAL GREAT MAZE POND city: LONDON postcode: SE1 9RT website: n.a. contact info title: n.a. name: n.a. surname: n.a. function: n.a. email: n.a. telephone: n.a. fax: n.a.	UK (LONDON)	participant	281˙681.00
11	EURAM LIMITED EURAM LIMITED Organization address address: LUCY TOWER STREET TOWER HOUSE city: LINCOLN postcode: LN1 1XW website: www.euram.ltd.uk contact info title: n.a. name: n.a. surname: n.a. function: n.a. email: n.a. telephone: n.a. fax: n.a.	UK (LINCOLN)	participant	65˙496.00
12	THE UNIVERSITY OF MANCHESTER THE UNIVERSITY OF MANCHESTER Organization address address: OXFORD ROAD city: MANCHESTER postcode: M13 9PL website: www.manchester.ac.uk contact info title: n.a. name: n.a. surname: n.a. function: n.a. email: n.a. telephone: n.a. fax: n.a.	UK (MANCHESTER)	participant	30˙700.00
13	MEDIZINISCHE UNIVERSITAET WIEN MEDIZINISCHE UNIVERSITAET WIEN Organization address address: SPITALGASSE 23 city: WIEN postcode: 1090 website: www.meduniwien.ac.at contact info title: n.a. name: n.a. surname: n.a. function: n.a. email: n.a. telephone: n.a. fax: n.a.	AT (WIEN)	participant	2˙546.00
14	UNIVERSITY HOSPITAL OF SOUTH MANCHESTER NHS FOUNDATION TRUST UNIVERSITY HOSPITAL OF SOUTH MANCHESTER NHS FOUNDATION TRUST Organization address address: SOUTHMOOR ROAD WYTHENSHAWE city: MANCHESTER postcode: M239LT website: www.uhsm.nhs.uk contact info title: n.a. name: n.a. surname: n.a. function: n.a. email: n.a. telephone: n.a. fax: n.a.	UK (MANCHESTER)	participant	0.00

Map

Project objective

CLINICAL PROBLEM AND UNMET NEED There are 11,827 patients with severe structural airway disease in Europe. Even with the current standard of care, when hospitalised this group of patients has a 22% risk of dying. Patients are currently subjected to repeated surgical interventions (stent insertion) which have a high failure rate.

Other therapeutic strategies under development include synthetic tracheal scaffolds seeded with patients own stem cells. Preliminary data show that these scaffolds are poorly integrated and are susceptible to infection.

TETRA PROJECT Our SME-led project will address the limitations of standard clinical care and competitor products under development and will: - Build on our successful compassionate use experience using autologous stem cell seeded scaffold-tracheal transplants in 48 patients - Follow on from our Phase I 4 patient INSPIRE clinical trial which will improve on the clinical prototype used in compassionate use cases - Conduct a 48 patient Phase II pivotal clinical trial to provide robust, quality data with validated GMP manufacturing processes to support an accelerated route to market for commercial exploitation in this orphan indication - Prepare a dossier for MAA submission

BENEFITS Our product, an ATMP, aims to eliminate the need for repeated surgical interventions of high risk and limited efficacy, reduce deaths and improve the quality of life for surviving patients. If treating 20% of the patients with severe structural airway disease, we estimate that in Europe our technology will improve the quality and length of patient lives and result in savings of €517 million per year.

We plan to further develop our platform technology to generate other complex tissues/organs such as bowel and liver replacements for clinical applications which will impact the lives of tens of thousands of patient in the EU with bowel and liver diseases.

Deliverables

List of deliverables.
Project Website	Websites, patent fillings, videos etc.	2019-05-31 18:06:05

Take a look to the deliverables list in detail: detailed list of TETRA deliverables.

Are you the coordinator (or a participant) of this project? Plaese send me more information about the "TETRA" project.

For instance: the website url (it has not provided by EU-opendata yet), the logo, a more detailed description of the project (in plain text as a rtf file or a word file), some pictures (as picture files, not embedded into any word file), twitter account, linkedin page, etc.

Send me an email (fabio@fabiodisconzi.com) and I put them in your project's page as son as possible.

Thanks. And then put a link of this page into your project's website.

The information about "TETRA" are provided by the European Opendata Portal: CORDIS opendata.